𝛼SK or Search

ENTITY

Fusion Pharmaceuticals (FUSN US)

3

Analysis

Health Care • Canada

Fusion Pharmaceuticals Inc. operates as a biopharmaceutical company. The Company discovers and develops novel targeted alpha therapeutics (TAT) and radiopharmaceuticals for the diagnosis and treatment of chemotherapy resistant cancers. Fusion Pharmaceuticals serves health care sectors in Canada.

more

Refresh

Exchange Announcement • 05 Jun 2024 04:18

Current Report (Form 8-K | Period ending 2024-06-04)

Exchange Announcement • 01 Jun 2024 04:12

Current Report (Form 8-K | Period ending 2024-05-31)

Exchange Announcement • 30 May 2024 04:34

Current Report (Form 8-K | Period ending 2024-05-29)

Exchange Announcement • 10 May 2024 19:54

Current Report (Form 8-K | Period ending 2024-05-10)

Exchange Announcement • 07 May 2024 20:00

Quarterly Report (Form 10-Q | Period ending 2024-03-31)

Copyright © 2022 Smartkarma Innovations Pte Ltd. All Rights Reserved. v3.70.4

x